{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:08:45Z","timestamp":1756462125976},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/rhu.0b013e3181f3c003","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T13:12:45Z","timestamp":1467033165000},"page":"330-331","source":"Crossref","is-referenced-by-count":4,"title":["Oral Tuberculosis in a Patient With Rheumatoid Arthritis After Long Treatment With Methotrexate and Adalimumab"],"prefix":"10.1097","volume":"16","author":[{"given":"Georgia","family":"Barouta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Karapetsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evanthia","family":"Kostopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Koukoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"15","key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.24476","article-title":"Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.","volume":"61","author":"Brassard","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R3-6-20210207","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than soluble tumor necrosis factor receptor therapy.","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-6-20210207","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R6-6-20210207","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R7-6-20210207","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the high susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.","volume":"162","author":"Bean","year":"1999","journal-title":"J Immunol"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","article-title":"Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-.","volume":"168","author":"Olleros","year":"2002","journal-title":"J Immunol"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"R10-6-20210207","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumor necrosis factor antagonists: structure, function, and tuberculosis risks.","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R11-6-20210207","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00054725-200411000-00015","article-title":"Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.","volume":"10","author":"Ringheanu","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"R12-6-20210207","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","article-title":"Tumor necrosis factor blockers: differential effects on mycobacterial immunity.","volume":"194","author":"Saliu Oy, Sofer","year":"2006","journal-title":"J Infect Dis"},{"key":"R13-6-20210207","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/517519","article-title":"Neutralization of tumor necrosis factor (TNF) by antibody but not soluble TNF receptor fusion molecule exacerbates chronic murine tuberculosis.","volume":"195","author":"Plessner","year":"2007","journal-title":"J Infect Dis"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard.62.4.372","article-title":"Tuberculous tonsillitis in a patient receiving etanercept treatment.","volume":"62","author":"Derk","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0714.2006.00363.x","article-title":"Oral tuberculosis associated with treatment with anti-rheumatic drugs.","volume":"35","author":"Kolokotronis","year":"2006","journal-title":"J Oral Pathol Med"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e3181f3c003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T01:21:30Z","timestamp":1692408090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201010000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181f3c003","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}